Breast Cancer and HIV: State of the Art and Practical Implications
Breast cancer is most common in women, and its incidence in HIV population, after the introduction of antiretroviral therapy, has increased to a level approaching that of the general population. This review will be focused on breast cancer in HIV-positive patients with particular reference to epidem...
Saved in:
Published in: | SN comprehensive clinical medicine Vol. 3; no. 8; pp. 1727 - 1739 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Cham
Springer International Publishing
08-05-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Breast cancer is most common in women, and its incidence in HIV population, after the introduction of antiretroviral therapy, has increased to a level approaching that of the general population. This review will be focused on breast cancer in HIV-positive patients with particular reference to epidemiology, screening strategies, clinico-pathological features, and treatment, including the interaction between chemotherapy and HAART. Recent cohort studies on HIV-positive women have clearly shown a shift towards increasing breast cancer incidence, with levels now approaching those in the HIV-negative population. Screening disparities exist yet between HIV-positive and HIV-negative women emphasizing the importance of biennial mammography to detect early breast cancer in women aged 50–74 years, who live with HIV/AIDS. Cancer stage, cancer pathology characteristics, and survival outcome are similar in HIV-positive and HIV-negative patients, although the fear of additional complications and toxicity often leads to HIV-positive patients receiving sub-optimal treatment. The best management of breast cancer in HIV patients consists in a multidisciplinary approach between oncologists and infectious disease specialists to guarantee the patients the correct diagnostic work-up and the most appropriate therapeutic approach aiming to reduce drug-drug interactions and overlapping toxicities of both treatments. |
---|---|
ISSN: | 2523-8973 2523-8973 |
DOI: | 10.1007/s42399-021-00950-z |